TRACON Pharmaceuticals Garners $36,000,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=15414aef-50f3-4c7f-817a-04838d12c7e0
Date
1/30/2015
Company Name
TRACON Pharmaceuticals
Mailing Address
8910 University Center Dr. San Diego, CA 92122 USA
Company Description
TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) is a biotechnology company developing next-generation targeted therapies for cancer and related diseases. We are addressing unmet needs in this arena with product candidates that focus on cellular targets specifically implicated in cancer growth and angiogenesis.
Website
http://www.traconpharma.com
Transaction Type
IPO
Transaction Amount
$36,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC.
M&A Terms